TrimRX
US$ 27.62
glp-1 and crohn's Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases Obesity and/or Diabetes: A Target Trial Emulation GLP-1 Medicines And Gut Bacterial
Description
Our dedicated medical team remains committed to staying at the forefront of these developments, ensuring that our patients have access to the most effective and safe weight loss solutions available
These have been widely tested and shown to be safe for this purpose
I received requests from a number of you to write about this situation
Use of incretin mimetics as initial therapy for people with type 2 diabetes and obesity was not considered cost effective
1 2 Expert Opinion on Pharmacotherapy
Page et al., 2013
